Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We found suggestive evidence that endometriosis contributes to higher serum 25-hydroxyvitamin D (β: 0.010, 95% CI: 0.002 to 0.02, P = .016).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Causal effects of endometriosis on serum 25-hydroxyvitamin D: Evidence from Mendelian randomization study

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Causal effects of endometriosis on serum 25-hydroxyvitamin D: Evidence from Mendelian randomization study

Genetic instrumental-variable study · Medicine · 2026

Original publication title

Causal effects of endometriosis on serum 25-hydroxyvitamin D: Evidence from Mendelian randomization study

Hongkun Jiang; Yinghua Tang; Ximei Huang; Zila Wang; Faquan Lin

Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Our bidirectional MR analysis produced evidence indicating that 25-hydroxyvitamin D is not causally associated with the risk of developing endometriosis. However, there is suggestive evidence that endometriosis may lead to slightly elevated serum 25-hydroxyvitamin D levels, though this finding is not robust across methods and requires further investigation.

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Endometriosis (EMs) is a clinical condition characterized by a chronic inflammatory response to estrogen that mostly affects pelvic tissues, including the ovaries.[1] Endometriosis is a common disorder resulting infertility in women.[2] Worldwide, 5% to 10% of women who are fertile are affected by endometriosis.[3] Additionally, the currently available pharmacological and surgical therapies are ineffective.[4,5] Vitamin D is a fat-soluble vitamin, with 25-hydroxyvitamin D as its primary circulating form.[6] It may play roles in reproductive health, including recurrent pregnancy loss and dysmenorrhea.[7Not reported9]

A prospective cohort study suggested that higher serum 25-hydroxyvitamin D levels and increased consumption of dairy products are connected with a lower risk of endometriosis.[10,11] Consuming ice cream and yogurt during youth may lower the likelihood of emergence and growth of endometriosis later in life.[12] In contrast, a case-control study suggested that consumption of milk was not significantly related to endometriosis.[13] As shown above, the results of research on the correlation between 25-hydroxyvitamin D and endometriosis have been conflicting.

Thus, further investigation is warranted.

Furthermore, observational studies cannot infer causality for the function of 25-hydroxyvitamin D in the occurrence and development of endometriosis. Potential drawbacks of these studies include reverse causality and confounding factors, which might mask the underlying causal relationship. The discovery of genetic variants that determine serum 25-hydroxyvitamin D levels may assist in obtaining more accurate estimates of the relationship with minimized bias due to confounding.

Genome-wide association studies (GWAS) are a powerful tool for identify millions of SNPs that mediate susceptibility to certain disorders in the past 10 years. Cohort or case-control research designs are used in GWAS to evaluate complex features, and the findings are typically posted in open-access databases, such as the Integrative Epidemiology Unit GWAS database or the GWAS catalog.

Mendelian randomization (MR) is a new statistical strategy that using single-nucleotide polymorphisms (SNPs) as instrumental variables (IVs) for the identification of potential causative influence between exposure and outcome.[14Not reported16] This approach can be used to examine these publicly available GWAS results.[17] Therefore, in this study, we used MR to explore the causative influence between 25-hydroxyvitamin D and endometriosis.

Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction Source: 1. Introduction

Study methods

What methods does the paper describe?

2.2. Mendelian randomization

MR is a valuable tool for determining causation in observational data.[18] Compared with traditional observational study design, MR can avoid the problems of confounding effects or reverse causality. It permits the testing of causation, thereby potentially helping to understand and prevent the adverse consequences of modifiable exposures on human health.[17,19,20]

With ever-increasing in sample sizes of GWAS, genetic variants linked to 25-hydroxyvitamin D and endometriosis have been recently recognized.[21] We are unaware of any studies that have attempted to use MR to explore the potential causative influence between 25-hydroxyvitamin D and endometriosis. In this research, we performed a MR study (first MR analysis) to determine genetically proxied serum 25-hydroxyvitamin D causally affected the risk of endometriosis. Furthermore, in the second MR analysis, we examined whether endometriosis exerts the same causal effect on serum 25-hydroxyvitamin D.

2.3. GWAS data source

This bidirectional MR study relied on GWAS. To perform MR analyses, we selected SNPs as instrumental variants (IVs) for serum 25-hydroxyvitamin D (ebi-a-GCST90000618; n = 4,96,946) and endometriosis (finn-b-N14_ENDOMETRIOSIS; n = 8288).[22] Subsequently, we chose SNPs from serum 25-hydroxyvitamin D and endometriosis studies that only enrolled individuals of European ancestry. We preferred data sources with large sample sizes, and solely female individuals. Of note, female-only GWAS have not been conducted thus far.

2.4. Genetic variables

We carried out a number of quality control procedures for the selection of eligible IVs. Specifically, after identifying the SNPs from the GWAS, the clump function was used to ensure their independence. To determine the R2-value, we used the standard formula for a continuous trait: R2 = 2 × EAF × (1 − EAF) × β2. Thereafter, to meet the first MR assumption, we used the expected value of the F-statistic to assess the overall efficacy of the 95 chosen SNPs in explaining 25-hydroxyvitamin D.[23,24] Similarly, 9 chosen SNPs were used as IVs for our reverse MR.

Menstrual cycle length, body mass index (BMI) and body weight are endometriosis-relevant features that may be confounders in the correlation between 25-hydroxyvitamin D and endometriosis.[25] In order to meet the second MR assumption, we excluded the IVs that arrogated these endometriosis-relevant features at R2 > 0.80 using PhenoScannerV2 database.[26,27] We specifically checked for associations with potential confounders such as BMI, smoking, alcohol consumption, and sun exposure. Next, we harmonized the 25-hydroxyvitamin D and endometriosis data by eliminating palindromic SNPs.

A palindromic SNP is one whose potential alleles couple with each other within the double helix structure; allele frequencies between 0.01 and 0.30 were referred to as intermediate allele frequencies.

2.5. Estimation of causal effect

We created a list of SNPs and performed MR analysis using Inverse-variance weighted (IVW) method. Its technique considers single SNP to be a genuine natural experiment, computes the Wald ratio and then integrates the findings using an IVW meta-analysis methodology. And the estimated slope parameter obtained from this method may indicate the causal influence of the exposure on the result. In addition, we calculated the odds ratios (OR) for effect estimates and 95% confidence intervals (CIs). Hence, IVW estimation may yield the most precise results.

We also performed MR analysis using multiple methods to make conclusions more reliable, such as weighted median (WM), MR-Egger, simple mode, and weighted mode methods.

We performed heterogeneity and pleiotropy analyses to assess the robustness of the results using the “leave-one-out” sensitivity analysis and MR-PRESSO analysis.[18,28,29] Q-statistics and I2-values analyze can be valuable in assessing the pleiotropy of IVs.[30]

2.6. Statistical analysis

We obtained MR estimates using the “devtools,” “MRCIEU/TwoSampleMR,” “MR-PRESSO,” and “LDlinkR” functions in R statistical software (version 4.2.2). Of note, P-values < .05 denoted a causative relationship between exposures and outcomes. Figure 1 displays the 2-sample Mendelian randomization (2SMR) analysis flowchart.

Figure 1.

Flowchart of the 2SMR analysis. Genetic variants were used as instrumental variables (IVs) to assess the causal effect of an exposure (forward direction: 25-hydroxyvitamin D; reverse direction: endometriosis 25-hydroxyvitamin) on an outcome (forward direction: endometriosis; reverse direction: 25-hydroxyvitamin D). 2SMR, 2-sample Mendelian randomization, IV = instrumental variable, IVW = inverse-variance weighted, MR = Mendelian randomization, WM = weighted median.

Figure image at the original source: open the original paper. This file is not included in this text import.
Source: 2. Materials and methods Source: 2. Materials and methods Source: 2. Materials and methods Source: 2. Materials and methods Source: 2. Materials and methods

Effect of serum 25-hydroxyvitamin D on endometriosis

Results: Effect of serum 25-hydroxyvitamin D on endometriosis

In our first MR, including 95 SNPs as IVs, we estimated the causative influence between 25-hydroxyvitamin D and endometriosis. Information on the 95 SNPs with 25-hydroxyvitamin D and endometriosis are presented in Table S1, Supplemental Digital Content. Cumulative F-statistic value for these 95 selected SNPs was 36.87, indicating that the entire collection of 95 SNPs satisfied the highly relevant assumption of MR.

Table 1 and Figure 2 show the results of the IVW (OR: 1.040, 95% CI: 0.890 to 1.230, P = .606), MR-Egger (OR: 1.190, 95% CI: 0.930 to 1.520, P = .171), weighted median (OR: 1.090, 95% CI: 0.860 to 1.390, P = .457), simple mode (OR: 1.510, 95% CI: 0.990 to 2.310, P = .058), and weighted mode (OR: 1.180, 95% CI: 0.970 to 1.440, P = .105) methods using 95 SNPs. The results of IVW method did not reveal a causative influence of 25-hydroxyvitamin D on endometriosis. Results of MR-Egger, weighted mode, weighted median and simple mode were consistent.

Table 1

MR analysis for the causality of serum 25-hydroxyvitamin D with the risk of endometriosis.

Exposure/outcomeNsnpMethodsOR (95% CI)SEP-valuePleiotropyHeterogeneity R 2 F
MR-Egger regressionCochran Q I 2 P-value
Egger interceptSEP-value
Serum 25-hydroxyvitamin D/endometriosis95IVW1.04 (0.89 to 1.23)0.08.606−0.0050.003.171113.7700.170.0810.00736.870
MR Egger1.19 (0.93 to 1.52)0.13.171
Weighted median1.09 (0.86 to 1.39)0.12.457
Simple mode1.51 (0.99 to 2.31)0.21.058
Weighted mode1.18 (0.97 to 1.44)0.10.105

CI = confidence interval, I2 = heterogeneity index, IVW = inverse-variance weighted, MR = Mendelian randomization, Nsnp = number of single-nucleotide polymorphisms, OR = odds ratio; SE = standard error.

Figure 2.

Mendelian randomization analysis of serum 25-hydroxyvitamin D to endometriosis using different methods. CI = confidence interval, IVW = inverse-variance weighted, MR = Mendelian randomization, OR = odds ratio, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.

In the test of heterogeneity, Q-statistics and I2-values did not reveal significant heterogeneity (Q = 113.77, I2 = 0.171, P = .081). We use “leave-one-out” analysis to identify pleiotropic variants. The results revealed that removal of any SNP from the principal MR analysis would not alter the MR estimates (Fig. 3A). In addition, the MR-Egger analysis did not reveal a pleiotropic effect (intercept = −0.005, SE = 0.003, P = .171; Fig. 3B).

Interestingly, the outlier-corrected MR-PRESSO technique failed to identify any outlying SNP (causal estimate = 0.043, standard deviation = 0.082, T-statistic = 0.519, P = .605). Plots of the causal effect estimate and sensitivity are shown in Figure 3. Therefore, our primary MR study was reliable, as demonstrated by the lack of observable heterogeneity and pleiotropy. In conclusion, our primary 2SMR analyses with 5 methods consistently demonstrated no evidence of causative influence between 25-hydroxyvitamin D and endometriosis.

Figure 3.

Effect of serum 25-hydroxyvitamin D on endometriosis. (A) Leave-one-out plot. (B) Scatter plot. (C) Forest plot. (D) Funnel plot. MR = Mendelian randomization, SE = standard error, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.
Source: 3.1. Effect of serum 25-hydroxyvitamin D on endometriosis Source: 3.1. Effect of serum 25-hydroxyvitamin D on endometriosis Source: 3.1. Effect of serum 25-hydroxyvitamin D on endometriosis Source: 3.1. Effect of serum 25-hydroxyvitamin D on endometriosis Source: 3.1. Effect of serum 25-hydroxyvitamin D on endometriosis Source: 3.1. Effect of serum 25-hydroxyvitamin D on endometriosis

Effect of endometriosis on serum 25-hydroxyvitamin D

Results: Effect of endometriosis on serum 25-hydroxyvitamin D

In our second MR, 9 SNPs were selected for reverse-direction MR analyses to examine whether endometriosis has a causal influence on 25-hydroxyvitamin D levels. In the PhenoScanner search, no SNP was found to be associated with 25-hydroxyvitamin D. Table S2, Supplemental Digital Content shows the information on SNPs linked to endometriosis and their association with 25-hydroxyvitamin D. The cumulative F-statistic value for these 9 selected SNPs was 53.60, indicating that these SNPs were a suitable endometriosis proxy to determine the causative influence.

While the IVW method suggested a potential causal effect of endometriosis on serum 25-hydroxyvitamin D (β: 0.010, 95% CI: 0.002 to 0.020, P = .016; Table 2), more robust methods such as MR-Egger (β: 0.030 95% CI: −0.0803 to 0.070, P = .093), weighted median (β: 0.010, 95% CI: −0.004 to 0.020, P = .147), simple mode (β: 0.010, 95% CI: −0.010 to 0.040, P = .392), and weighted mode (β: 0.010, 95% CI: −0.010 to 0.040, P = .368) did not yield significant results (Table 2 and Fig 4), indicating that this finding should be interpreted with caution.

As visually apparent in the scatter plot (Fig. 5B) and method comparison (Fig. 4), the significant effect was driven by the IVW method, while the MR-Egger and Weighted Median estimates were consistent with a null effect, suggesting the finding may not be robust to potential pleiotropy.

Table 2

MR analysis for the causality of endometriosis with the levels of serum 25-hydroxyvitamin D.

Exposure/outcomeNsnpMethodsβ (95% CI)SEP-valuePleiotropyHeterogeneity R 2 F
MR-Egger regressionCochran Q I 2 P-value
Egger interceptSEP-value
Endometriosis/serum 25-hydroxyvitamin D levels9IVW0.010 (0.002 to 0.020)0.004.016−0.0030.003.2466.1200.340.6300.00153.600
MR Egger0.030 (−0.0003 to 0.070)0.020.093
Weighted median0.010 (−0.004 to 0.020)0.006.147
Simple mode0.010 (−0.010 to 0.040)0.013.392
Weighted mode0.010 (−0.010 to 0.037)0.010.368

The significant effect is driven by IVW, with methodological discrepancy across more robust methods.

CI = confidence interval, I2 = heterogeneity index, IVW = inverse-variance weighted, MR = Mendelian randomization, Nsnp = number of single-nucleotide polymorphisms, SE = standard error.

Figure 4.

Mendelian randomization analysis of endometriosis to serum 25-hydroxyvitamin D using different methods. CI = confidence interval, IVW = inverse-variance weighted, MR = Mendelian randomization, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 5.

Effect of endometriosis on serum 25-hydroxyvitamin D levels. (A) Leave-one-out plot. (B) Scatter plot. (C) Forest plot. (D) Funnel plot. MR = Mendelian randomization, SE = standard error, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.

MR-Egger regression did not detect a pleiotropic effect (intercept = −0.003, SE = 0.003, P = .246; Fig. 5B). Likewise, no heterogeneity was found using Q-statistics and I2-values (Q = 6.120, I2 = 0.340, P = .630). Plot for the “leave-one-out” sensitivity analysis indicated that the causal correlation between genetically predicted endometriosis on serum 25-hydroxyvitamin D was not substantially driven by any single SNP (Fig. 5A). A scatter plot showing the relationship between the SNP for endometriosis and the SNP for 25-hydroxyvitamin D using several MR techniques and sensitivity analysis (Fig. 5B).

Forest plot indicate a causal relationship between genetically proxied endometriosis and the 25-hydroxyvitamin D levels based on IVW methods (P < .05) using 9 SNPs (Fig. 5C). In conclusion, our reverse 2SMR analyses provide suggestive but not robust evidence of a potential causal influence of endometriosis on serum 25-hydroxyvitamin D levels.

Source: 3.2. Effect of endometriosis on serum 25-hydroxyvitamin D Source: 3.2. Effect of endometriosis on serum 25-hydroxyvitamin D Source: 3.2. Effect of endometriosis on serum 25-hydroxyvitamin D Source: 3.2. Effect of endometriosis on serum 25-hydroxyvitamin D Source: 3.2. Effect of endometriosis on serum 25-hydroxyvitamin D Source: 3.2. Effect of endometriosis on serum 25-hydroxyvitamin D

Causative influence of serum 25-hydroxyvitamin D on endometriosis

Discussion: Causative influence of serum 25-hydroxyvitamin D on endometriosis

Several observational studies have shown the connection between 25-hydroxyvitamin D and the development of endometriosis. According to a prospective cohort research study, higher 25-hydroxyvitamin D levels are associated with a lower risk of endometriosis.[10] In another prospective cohort research suggested that consumption of dairy in adolescence, namely the intake of yogurt and ice cream, might be a method to lower the risk of developing endometriosis.[12] Additionally, a systematic literature review uncovered that dietary consumption of vitamin D and the concentration of serum 25-hydroxyvitamin D may affect the risk of endometriosis.[31] However, these observational studies may be confined by potential limitations (e.g., reverse causality and confounding factors), which obscure the true causal relationship.

In our study, the findings of our forward-direction MR analysis were inconsistent with the outcomes of earlier observational investigations. We did not detect any causative influence of serum 25-hydroxyvitamin D on endometriosis.

Our MR analysis helps clarify the relationship suggested in previous observational studies and found no evidence supporting a causal effect of serum 25-hydroxyvitamin D on endometriosis. The differences between the results obtained from observational and MR investigations can be attributed to the intrinsic advantage of the latter over the former, as well as methodological flaws in observational research.

Source: 4.1. Causative influence of serum 25-hydroxyvitamin D on endometriosis Source: 4.1. Causative influence of serum 25-hydroxyvitamin D on endometriosis Source: 4.1. Causative influence of serum 25-hydroxyvitamin D on endometriosis

Causative influence of endometriosis on serum 25-hydroxyvitamin D

Discussion: Causative influence of endometriosis on serum 25-hydroxyvitamin D

Clinical research performed by Somigliana et al demonstrated that endometriosis was linked to higher levels of serum 25-hydroxyvitamin D.[32] Another clinical investigation on endometriosis patients discovered higher levels of vitamin D-binding protein (VDBP) in their urine.[33] However, according to an in vitro research study, women with severe endometriosis had considerably lower blood levels of 25-hydroxyvitamin D than controls and those with moderate endometriosis.[34] Nonetheless, whether endometriosis is responsible for the higher levels of serum 25-hydroxyvitamin D remains largely unexplored.

Recently, a bidirectional MR study by Pan D and colleagues published in Reproductive Sciences investigated the causal relationship between serum 25-hydroxyvitamin D levels and endometriosis. Their analysis suggested a potential bidirectional association between vitamin D status and the risk of endometriosis.[35] While their findings provide important insights into the interplay between vitamin D metabolism and endometriosis, our study differs in several aspects. First, we used a different GWAS dataset for serum 25-hydroxyvitamin D that included a larger sample size, which may improve the statistical power and robustness of the MR analysis.

Second, although both studies employed bidirectional MR approaches, our analysis further evaluated the potential causal influence of endometriosis on circulating vitamin D levels using additional sensitivity analyses. Therefore, our results provide complementary evidence supporting the possible interaction between endometriosis and vitamin D metabolism.

Our reverse-direction MR research provides suggestive evidence for a causal effect of endometriosis on serum 25-hydroxyvitamin D. If there is a causal effect, it is likely small and may reflect the inflammatory state of the disease. In line with clinical trial that human cycling endometrium may be one of the extrarenal locations capable of vitamin D synthesis.[8] The potential effect of endometriosis on 25-hydroxyvitamin D may be related to inflammation, as endometriosis is an inflammatory condition where macrophages mediate responses.[36] For instance, activated macrophages may produce 25-hydroxyvitamin D that spills into circulation.[37] A previous MR study indicated high levels of macrophage colony-stimulating factor (MCSF) are associated with increased risks of endometriosis.[38] However, this mechanism is speculative and should be framed as a hypothesis.

Our MR analyses were based on the PhenoScannerV2 database; hence, they are superior to existing observational research in terms of significantly reduced confounding bias.

Source: 4.2. Causative influence of endometriosis on serum 25-hydroxyvitamin D Source: 4.2. Causative influence of endometriosis on serum 25-hydroxyvitamin D Source: 4.2. Causative influence of endometriosis on serum 25-hydroxyvitamin D Source: 4.2. Causative influence of endometriosis on serum 25-hydroxyvitamin D

Discussion: Heterogeneity and pleiotropy

In addition, several heterogeneity and pleiotropy analyses were conducted to investigate potential pleiotropy. These analyses showed no significant heterogeneity or pleiotropy in the forward MR estimates (e.g., Q = 113.77, I2 = 0.171, P = .081; MR-Egger intercept = −0.0051, P = .171). For the reverse MR, no heterogeneity was detected (Q = 6.120, I2 = 0.340, P = .630), and MR-Egger regression indicated no directional pleiotropy (intercept = −0.003, P = .246).

The reverse MR finding showed conflicting results between methods, with only the IVW method being significant while more robust methods (MR-Egger and weighted median) were not. This implies that the evidence for a causal effect is suggestive but not conclusive, potentially due to pleiotropy or other biases, and warrants cautious interpretation and replication in future studies.

Source: 4.3. Heterogeneity and pleiotropy Source: 4.3. Heterogeneity and pleiotropy

Discussion: Strength and limitations

To our knowledge, this study provides additional MR evidence regarding the relationship between serum 25-hydroxyvitamin D and endometriosis using updated GWAS datasets. In comparison to observational studies, the enormous sample size of GWAS summary datasets used in MR considerably reduced the degree of reverse causation and confounding bias.

However, our research is also characterized by several limitations. First, we did not provide a physiological explanation regarding the correlation between 25-hydroxyvitamin D and endometriosis. Second, our investigation focused on individuals of European ancestry; consequently, the results may not accurately reflect the relationship between 25-hydroxyvitamin D and endometriosis in individuals of different ancestries, such as Asians and Blacks. Thus, further research is warranted to generalize the present findings to non-European populations. Third, although endometriosis exclusively affects women, the serum 25-hydroxyvitamin D GWAS utilized in this investigation included both male and female participants.

Therefore, if new GWAS on serum 25-hydroxyvitamin D in females become available, it would be intriguing to conduct a similar study. Fourth, the relatively small sample size of the endometriosis GWAS (n = 8288) may lead to weak instrument bias, although F-statistics were strong (>10). Finally, the credibility of findings may also be somewhat compromised by any error in measurement. Thus, additional research on this topic should be conducted when larger and more comprehensive datasets become available to the general public.[39,40]

Therefore, the causal estimate for this direction should be considered preliminary and requires validation in future studies with stronger genetic instruments and consistent results across MR methods.

Source: 4.5. Strength and limitations Source: 4.5. Strength and limitations Source: 4.5. Strength and limitations

Results

3.1. Effect of serum 25-hydroxyvitamin D on endometriosis

In our first MR, including 95 SNPs as IVs, we estimated the causative influence between 25-hydroxyvitamin D and endometriosis. Information on the 95 SNPs with 25-hydroxyvitamin D and endometriosis are presented in Table S1, Supplemental Digital Content. Cumulative F-statistic value for these 95 selected SNPs was 36.87, indicating that the entire collection of 95 SNPs satisfied the highly relevant assumption of MR.

Table 1 and Figure 2 show the results of the IVW (OR: 1.040, 95% CI: 0.890 to 1.230, P = .606), MR-Egger (OR: 1.190, 95% CI: 0.930 to 1.520, P = .171), weighted median (OR: 1.090, 95% CI: 0.860 to 1.390, P = .457), simple mode (OR: 1.510, 95% CI: 0.990 to 2.310, P = .058), and weighted mode (OR: 1.180, 95% CI: 0.970 to 1.440, P = .105) methods using 95 SNPs. The results of IVW method did not reveal a causative influence of 25-hydroxyvitamin D on endometriosis. Results of MR-Egger, weighted mode, weighted median and simple mode were consistent.

Table 1

MR analysis for the causality of serum 25-hydroxyvitamin D with the risk of endometriosis.

Exposure/outcomeNsnpMethodsOR (95% CI)SEP-valuePleiotropyHeterogeneity R 2 F
MR-Egger regressionCochran Q I 2 P-value
Egger interceptSEP-value
Serum 25-hydroxyvitamin D/endometriosis95IVW1.04 (0.89 to 1.23)0.08.606−0.0050.003.171113.7700.170.0810.00736.870
MR Egger1.19 (0.93 to 1.52)0.13.171
Weighted median1.09 (0.86 to 1.39)0.12.457
Simple mode1.51 (0.99 to 2.31)0.21.058
Weighted mode1.18 (0.97 to 1.44)0.10.105

CI = confidence interval, I2 = heterogeneity index, IVW = inverse-variance weighted, MR = Mendelian randomization, Nsnp = number of single-nucleotide polymorphisms, OR = odds ratio; SE = standard error.

Figure 2.

Mendelian randomization analysis of serum 25-hydroxyvitamin D to endometriosis using different methods. CI = confidence interval, IVW = inverse-variance weighted, MR = Mendelian randomization, OR = odds ratio, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.

In the test of heterogeneity, Q-statistics and I2-values did not reveal significant heterogeneity (Q = 113.77, I2 = 0.171, P = .081). We use “leave-one-out” analysis to identify pleiotropic variants. The results revealed that removal of any SNP from the principal MR analysis would not alter the MR estimates (Fig. 3A). In addition, the MR-Egger analysis did not reveal a pleiotropic effect (intercept = −0.005, SE = 0.003, P = .171; Fig. 3B).

Interestingly, the outlier-corrected MR-PRESSO technique failed to identify any outlying SNP (causal estimate = 0.043, standard deviation = 0.082, T-statistic = 0.519, P = .605). Plots of the causal effect estimate and sensitivity are shown in Figure 3. Therefore, our primary MR study was reliable, as demonstrated by the lack of observable heterogeneity and pleiotropy. In conclusion, our primary 2SMR analyses with 5 methods consistently demonstrated no evidence of causative influence between 25-hydroxyvitamin D and endometriosis.

Figure 3.

Effect of serum 25-hydroxyvitamin D on endometriosis. (A) Leave-one-out plot. (B) Scatter plot. (C) Forest plot. (D) Funnel plot. MR = Mendelian randomization, SE = standard error, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.

3.2. Effect of endometriosis on serum 25-hydroxyvitamin D

In our second MR, 9 SNPs were selected for reverse-direction MR analyses to examine whether endometriosis has a causal influence on 25-hydroxyvitamin D levels. In the PhenoScanner search, no SNP was found to be associated with 25-hydroxyvitamin D. Table S2, Supplemental Digital Content shows the information on SNPs linked to endometriosis and their association with 25-hydroxyvitamin D. The cumulative F-statistic value for these 9 selected SNPs was 53.60, indicating that these SNPs were a suitable endometriosis proxy to determine the causative influence.

While the IVW method suggested a potential causal effect of endometriosis on serum 25-hydroxyvitamin D (β: 0.010, 95% CI: 0.002 to 0.020, P = .016; Table 2), more robust methods such as MR-Egger (β: 0.030 95% CI: −0.0803 to 0.070, P = .093), weighted median (β: 0.010, 95% CI: −0.004 to 0.020, P = .147), simple mode (β: 0.010, 95% CI: −0.010 to 0.040, P = .392), and weighted mode (β: 0.010, 95% CI: −0.010 to 0.040, P = .368) did not yield significant results (Table 2 and Fig 4), indicating that this finding should be interpreted with caution.

As visually apparent in the scatter plot (Fig. 5B) and method comparison (Fig. 4), the significant effect was driven by the IVW method, while the MR-Egger and Weighted Median estimates were consistent with a null effect, suggesting the finding may not be robust to potential pleiotropy.

Table 2

MR analysis for the causality of endometriosis with the levels of serum 25-hydroxyvitamin D.

Exposure/outcomeNsnpMethodsβ (95% CI)SEP-valuePleiotropyHeterogeneity R 2 F
MR-Egger regressionCochran Q I 2 P-value
Egger interceptSEP-value
Endometriosis/serum 25-hydroxyvitamin D levels9IVW0.010 (0.002 to 0.020)0.004.016−0.0030.003.2466.1200.340.6300.00153.600
MR Egger0.030 (−0.0003 to 0.070)0.020.093
Weighted median0.010 (−0.004 to 0.020)0.006.147
Simple mode0.010 (−0.010 to 0.040)0.013.392
Weighted mode0.010 (−0.010 to 0.037)0.010.368

The significant effect is driven by IVW, with methodological discrepancy across more robust methods.

CI = confidence interval, I2 = heterogeneity index, IVW = inverse-variance weighted, MR = Mendelian randomization, Nsnp = number of single-nucleotide polymorphisms, SE = standard error.

Figure 4.

Mendelian randomization analysis of endometriosis to serum 25-hydroxyvitamin D using different methods. CI = confidence interval, IVW = inverse-variance weighted, MR = Mendelian randomization, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 5.

Effect of endometriosis on serum 25-hydroxyvitamin D levels. (A) Leave-one-out plot. (B) Scatter plot. (C) Forest plot. (D) Funnel plot. MR = Mendelian randomization, SE = standard error, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.

MR-Egger regression did not detect a pleiotropic effect (intercept = −0.003, SE = 0.003, P = .246; Fig. 5B). Likewise, no heterogeneity was found using Q-statistics and I2-values (Q = 6.120, I2 = 0.340, P = .630). Plot for the “leave-one-out” sensitivity analysis indicated that the causal correlation between genetically predicted endometriosis on serum 25-hydroxyvitamin D was not substantially driven by any single SNP (Fig. 5A). A scatter plot showing the relationship between the SNP for endometriosis and the SNP for 25-hydroxyvitamin D using several MR techniques and sensitivity analysis (Fig. 5B).

Forest plot indicate a causal relationship between genetically proxied endometriosis and the 25-hydroxyvitamin D levels based on IVW methods (P < .05) using 9 SNPs (Fig. 5C). In conclusion, our reverse 2SMR analyses provide suggestive but not robust evidence of a potential causal influence of endometriosis on serum 25-hydroxyvitamin D levels.

Source: 3. Results Source: 3. Results

Conclusion

Our bidirectional MR analysis produced evidence indicating that 25-hydroxyvitamin D is not causally associated with the risk of developing endometriosis. However, there is suggestive evidence that endometriosis may lead to slightly elevated serum 25-hydroxyvitamin D levels, though this finding is not robust across methods and requires further investigation.

Source: 5. Conclusion
Authors’ abstract

The potential bidirectional causal relationship between endometriosis and serum 25-hydroxyvitamin D has been previously investigated. Nevertheless, the results could be impacted by confounding factors and reverse causality because of the nature of observational research. Mendelian randomization (MR) circumvents the drawbacks of observational studies by providing estimates of unconfounded causal effects. We used bi-directional MR analysis to determine whether serum 25-hydroxyvitamin D had a causal influence on endometriosis and vice versa. Additionally, using heterogeneity and sensitivity analyses, we explored the heterogeneity and pleiotropy of effect estimates.

Similarly, we investigated the causal correlation between endometriosis and 25-hydroxyvitamin D through reverse-direction MR. In forward-direction MR, we selected 95 single-nucleotide polymorphisms (SNPs) as instrumental variants (IVs) to examine the potential causal influence between 25-hydroxyvitamin D and endometriosis. And we selected 9 SNPs as IVs for reverse-direction MR analyses to examine whether endometriosis has a causal influence on serum 25-hydroxyvitamin D. We found suggestive evidence that endometriosis contributes to higher serum 25-hydroxyvitamin D (β: 0.010, 95% CI: 0.002 to 0.02, P = .016).

Our data suggest that serum 25-hydroxyvitamin D levels may be a consequence of endometriosis rather than a causal risk factor, and its potential role in the disease process warrants further investigation.

Read the full paper

1. Introduction

Endometriosis (EMs) is a clinical condition characterized by a chronic inflammatory response to estrogen that mostly affects pelvic tissues, including the ovaries.[1] Endometriosis is a common disorder resulting infertility in women.[2] Worldwide, 5% to 10% of women who are fertile are affected by endometriosis.[3] Additionally, the currently available pharmacological and surgical therapies are ineffective.[4,5] Vitamin D is a fat-soluble vitamin, with 25-hydroxyvitamin D as its primary circulating form.[6] It may play roles in reproductive health, including recurrent pregnancy loss and dysmenorrhea.[7Not reported9]

A prospective cohort study suggested that higher serum 25-hydroxyvitamin D levels and increased consumption of dairy products are connected with a lower risk of endometriosis.[10,11] Consuming ice cream and yogurt during youth may lower the likelihood of emergence and growth of endometriosis later in life.[12] In contrast, a case-control study suggested that consumption of milk was not significantly related to endometriosis.[13] As shown above, the results of research on the correlation between 25-hydroxyvitamin D and endometriosis have been conflicting.

Thus, further investigation is warranted.

Furthermore, observational studies cannot infer causality for the function of 25-hydroxyvitamin D in the occurrence and development of endometriosis. Potential drawbacks of these studies include reverse causality and confounding factors, which might mask the underlying causal relationship. The discovery of genetic variants that determine serum 25-hydroxyvitamin D levels may assist in obtaining more accurate estimates of the relationship with minimized bias due to confounding.

Genome-wide association studies (GWAS) are a powerful tool for identify millions of SNPs that mediate susceptibility to certain disorders in the past 10 years. Cohort or case-control research designs are used in GWAS to evaluate complex features, and the findings are typically posted in open-access databases, such as the Integrative Epidemiology Unit GWAS database or the GWAS catalog.

Mendelian randomization (MR) is a new statistical strategy that using single-nucleotide polymorphisms (SNPs) as instrumental variables (IVs) for the identification of potential causative influence between exposure and outcome.[14Not reported16] This approach can be used to examine these publicly available GWAS results.[17] Therefore, in this study, we used MR to explore the causative influence between 25-hydroxyvitamin D and endometriosis.

2. Materials and methods

2.1. Ethical approval

This study analyzed publicly available, de-identified summary-level data from genome-wide association studies (GWAS). Therefore, separate ethical approval was not required for this specific analysis. The original GWAS studies obtained ethical approval from their respective institutional review boards (IRBs) and informed consent from all participants.

2.2. Mendelian randomization

MR is a valuable tool for determining causation in observational data.[18] Compared with traditional observational study design, MR can avoid the problems of confounding effects or reverse causality. It permits the testing of causation, thereby potentially helping to understand and prevent the adverse consequences of modifiable exposures on human health.[17,19,20]

With ever-increasing in sample sizes of GWAS, genetic variants linked to 25-hydroxyvitamin D and endometriosis have been recently recognized.[21] We are unaware of any studies that have attempted to use MR to explore the potential causative influence between 25-hydroxyvitamin D and endometriosis. In this research, we performed a MR study (first MR analysis) to determine genetically proxied serum 25-hydroxyvitamin D causally affected the risk of endometriosis. Furthermore, in the second MR analysis, we examined whether endometriosis exerts the same causal effect on serum 25-hydroxyvitamin D.

2.3. GWAS data source

This bidirectional MR study relied on GWAS. To perform MR analyses, we selected SNPs as instrumental variants (IVs) for serum 25-hydroxyvitamin D (ebi-a-GCST90000618; n = 4,96,946) and endometriosis (finn-b-N14_ENDOMETRIOSIS; n = 8288).[22] Subsequently, we chose SNPs from serum 25-hydroxyvitamin D and endometriosis studies that only enrolled individuals of European ancestry. We preferred data sources with large sample sizes, and solely female individuals. Of note, female-only GWAS have not been conducted thus far.

2.4. Genetic variables

We carried out a number of quality control procedures for the selection of eligible IVs. Specifically, after identifying the SNPs from the GWAS, the clump function was used to ensure their independence. To determine the R2-value, we used the standard formula for a continuous trait: R2 = 2 × EAF × (1 − EAF) × β2. Thereafter, to meet the first MR assumption, we used the expected value of the F-statistic to assess the overall efficacy of the 95 chosen SNPs in explaining 25-hydroxyvitamin D.[23,24] Similarly, 9 chosen SNPs were used as IVs for our reverse MR.

Menstrual cycle length, body mass index (BMI) and body weight are endometriosis-relevant features that may be confounders in the correlation between 25-hydroxyvitamin D and endometriosis.[25] In order to meet the second MR assumption, we excluded the IVs that arrogated these endometriosis-relevant features at R2 > 0.80 using PhenoScannerV2 database.[26,27] We specifically checked for associations with potential confounders such as BMI, smoking, alcohol consumption, and sun exposure. Next, we harmonized the 25-hydroxyvitamin D and endometriosis data by eliminating palindromic SNPs.

A palindromic SNP is one whose potential alleles couple with each other within the double helix structure; allele frequencies between 0.01 and 0.30 were referred to as intermediate allele frequencies.

2.5. Estimation of causal effect

We created a list of SNPs and performed MR analysis using Inverse-variance weighted (IVW) method. Its technique considers single SNP to be a genuine natural experiment, computes the Wald ratio and then integrates the findings using an IVW meta-analysis methodology. And the estimated slope parameter obtained from this method may indicate the causal influence of the exposure on the result. In addition, we calculated the odds ratios (OR) for effect estimates and 95% confidence intervals (CIs). Hence, IVW estimation may yield the most precise results.

We also performed MR analysis using multiple methods to make conclusions more reliable, such as weighted median (WM), MR-Egger, simple mode, and weighted mode methods.

We performed heterogeneity and pleiotropy analyses to assess the robustness of the results using the “leave-one-out” sensitivity analysis and MR-PRESSO analysis.[18,28,29] Q-statistics and I2-values analyze can be valuable in assessing the pleiotropy of IVs.[30]

2.6. Statistical analysis

We obtained MR estimates using the “devtools,” “MRCIEU/TwoSampleMR,” “MR-PRESSO,” and “LDlinkR” functions in R statistical software (version 4.2.2). Of note, P-values < .05 denoted a causative relationship between exposures and outcomes. Figure 1 displays the 2-sample Mendelian randomization (2SMR) analysis flowchart.

Figure 1.

Flowchart of the 2SMR analysis. Genetic variants were used as instrumental variables (IVs) to assess the causal effect of an exposure (forward direction: 25-hydroxyvitamin D; reverse direction: endometriosis 25-hydroxyvitamin) on an outcome (forward direction: endometriosis; reverse direction: 25-hydroxyvitamin D). 2SMR, 2-sample Mendelian randomization, IV = instrumental variable, IVW = inverse-variance weighted, MR = Mendelian randomization, WM = weighted median.

Figure image at the original source: open the original paper. This file is not included in this text import.

3. Results

3.1. Effect of serum 25-hydroxyvitamin D on endometriosis

In our first MR, including 95 SNPs as IVs, we estimated the causative influence between 25-hydroxyvitamin D and endometriosis. Information on the 95 SNPs with 25-hydroxyvitamin D and endometriosis are presented in Table S1, Supplemental Digital Content. Cumulative F-statistic value for these 95 selected SNPs was 36.87, indicating that the entire collection of 95 SNPs satisfied the highly relevant assumption of MR.

Table 1 and Figure 2 show the results of the IVW (OR: 1.040, 95% CI: 0.890 to 1.230, P = .606), MR-Egger (OR: 1.190, 95% CI: 0.930 to 1.520, P = .171), weighted median (OR: 1.090, 95% CI: 0.860 to 1.390, P = .457), simple mode (OR: 1.510, 95% CI: 0.990 to 2.310, P = .058), and weighted mode (OR: 1.180, 95% CI: 0.970 to 1.440, P = .105) methods using 95 SNPs. The results of IVW method did not reveal a causative influence of 25-hydroxyvitamin D on endometriosis. Results of MR-Egger, weighted mode, weighted median and simple mode were consistent.

Table 1

MR analysis for the causality of serum 25-hydroxyvitamin D with the risk of endometriosis.

Exposure/outcomeNsnpMethodsOR (95% CI)SEP-valuePleiotropyHeterogeneity R 2 F
MR-Egger regressionCochran Q I 2 P-value
Egger interceptSEP-value
Serum 25-hydroxyvitamin D/endometriosis95IVW1.04 (0.89 to 1.23)0.08.606−0.0050.003.171113.7700.170.0810.00736.870
MR Egger1.19 (0.93 to 1.52)0.13.171
Weighted median1.09 (0.86 to 1.39)0.12.457
Simple mode1.51 (0.99 to 2.31)0.21.058
Weighted mode1.18 (0.97 to 1.44)0.10.105

CI = confidence interval, I2 = heterogeneity index, IVW = inverse-variance weighted, MR = Mendelian randomization, Nsnp = number of single-nucleotide polymorphisms, OR = odds ratio; SE = standard error.

Figure 2.

Mendelian randomization analysis of serum 25-hydroxyvitamin D to endometriosis using different methods. CI = confidence interval, IVW = inverse-variance weighted, MR = Mendelian randomization, OR = odds ratio, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.

In the test of heterogeneity, Q-statistics and I2-values did not reveal significant heterogeneity (Q = 113.77, I2 = 0.171, P = .081). We use “leave-one-out” analysis to identify pleiotropic variants. The results revealed that removal of any SNP from the principal MR analysis would not alter the MR estimates (Fig. 3A). In addition, the MR-Egger analysis did not reveal a pleiotropic effect (intercept = −0.005, SE = 0.003, P = .171; Fig. 3B).

Interestingly, the outlier-corrected MR-PRESSO technique failed to identify any outlying SNP (causal estimate = 0.043, standard deviation = 0.082, T-statistic = 0.519, P = .605). Plots of the causal effect estimate and sensitivity are shown in Figure 3. Therefore, our primary MR study was reliable, as demonstrated by the lack of observable heterogeneity and pleiotropy. In conclusion, our primary 2SMR analyses with 5 methods consistently demonstrated no evidence of causative influence between 25-hydroxyvitamin D and endometriosis.

Figure 3.

Effect of serum 25-hydroxyvitamin D on endometriosis. (A) Leave-one-out plot. (B) Scatter plot. (C) Forest plot. (D) Funnel plot. MR = Mendelian randomization, SE = standard error, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.

3.2. Effect of endometriosis on serum 25-hydroxyvitamin D

In our second MR, 9 SNPs were selected for reverse-direction MR analyses to examine whether endometriosis has a causal influence on 25-hydroxyvitamin D levels. In the PhenoScanner search, no SNP was found to be associated with 25-hydroxyvitamin D. Table S2, Supplemental Digital Content shows the information on SNPs linked to endometriosis and their association with 25-hydroxyvitamin D. The cumulative F-statistic value for these 9 selected SNPs was 53.60, indicating that these SNPs were a suitable endometriosis proxy to determine the causative influence.

While the IVW method suggested a potential causal effect of endometriosis on serum 25-hydroxyvitamin D (β: 0.010, 95% CI: 0.002 to 0.020, P = .016; Table 2), more robust methods such as MR-Egger (β: 0.030 95% CI: −0.0803 to 0.070, P = .093), weighted median (β: 0.010, 95% CI: −0.004 to 0.020, P = .147), simple mode (β: 0.010, 95% CI: −0.010 to 0.040, P = .392), and weighted mode (β: 0.010, 95% CI: −0.010 to 0.040, P = .368) did not yield significant results (Table 2 and Fig 4), indicating that this finding should be interpreted with caution.

As visually apparent in the scatter plot (Fig. 5B) and method comparison (Fig. 4), the significant effect was driven by the IVW method, while the MR-Egger and Weighted Median estimates were consistent with a null effect, suggesting the finding may not be robust to potential pleiotropy.

Table 2

MR analysis for the causality of endometriosis with the levels of serum 25-hydroxyvitamin D.

Exposure/outcomeNsnpMethodsβ (95% CI)SEP-valuePleiotropyHeterogeneity R 2 F
MR-Egger regressionCochran Q I 2 P-value
Egger interceptSEP-value
Endometriosis/serum 25-hydroxyvitamin D levels9IVW0.010 (0.002 to 0.020)0.004.016−0.0030.003.2466.1200.340.6300.00153.600
MR Egger0.030 (−0.0003 to 0.070)0.020.093
Weighted median0.010 (−0.004 to 0.020)0.006.147
Simple mode0.010 (−0.010 to 0.040)0.013.392
Weighted mode0.010 (−0.010 to 0.037)0.010.368

The significant effect is driven by IVW, with methodological discrepancy across more robust methods.

CI = confidence interval, I2 = heterogeneity index, IVW = inverse-variance weighted, MR = Mendelian randomization, Nsnp = number of single-nucleotide polymorphisms, SE = standard error.

Figure 4.

Mendelian randomization analysis of endometriosis to serum 25-hydroxyvitamin D using different methods. CI = confidence interval, IVW = inverse-variance weighted, MR = Mendelian randomization, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure 5.

Effect of endometriosis on serum 25-hydroxyvitamin D levels. (A) Leave-one-out plot. (B) Scatter plot. (C) Forest plot. (D) Funnel plot. MR = Mendelian randomization, SE = standard error, SNP = single-nucleotide polymorphism.

Figure image at the original source: open the original paper. This file is not included in this text import.

MR-Egger regression did not detect a pleiotropic effect (intercept = −0.003, SE = 0.003, P = .246; Fig. 5B). Likewise, no heterogeneity was found using Q-statistics and I2-values (Q = 6.120, I2 = 0.340, P = .630). Plot for the “leave-one-out” sensitivity analysis indicated that the causal correlation between genetically predicted endometriosis on serum 25-hydroxyvitamin D was not substantially driven by any single SNP (Fig. 5A). A scatter plot showing the relationship between the SNP for endometriosis and the SNP for 25-hydroxyvitamin D using several MR techniques and sensitivity analysis (Fig. 5B).

Forest plot indicate a causal relationship between genetically proxied endometriosis and the 25-hydroxyvitamin D levels based on IVW methods (P < .05) using 9 SNPs (Fig. 5C). In conclusion, our reverse 2SMR analyses provide suggestive but not robust evidence of a potential causal influence of endometriosis on serum 25-hydroxyvitamin D levels.

4. Discussion

Endometriosis is a common clinical gynecological disorder in women. In this study, we performed systemic 2SMR analysis using a stronger genetic instrument versus conventional methods to identify any links between endometriosis and serum 25-hydroxyvitamin D. Furthermore, our bidirectional MR analysis did not detect a causal influence of 25-hydroxyvitamin D on the development of endometriosis; however, we found suggestive evidence that endometriosis may be associated with slightly elevated 25-hydroxyvitamin D levels.

4.1. Causative influence of serum 25-hydroxyvitamin D on endometriosis

Several observational studies have shown the connection between 25-hydroxyvitamin D and the development of endometriosis. According to a prospective cohort research study, higher 25-hydroxyvitamin D levels are associated with a lower risk of endometriosis.[10] In another prospective cohort research suggested that consumption of dairy in adolescence, namely the intake of yogurt and ice cream, might be a method to lower the risk of developing endometriosis.[12] Additionally, a systematic literature review uncovered that dietary consumption of vitamin D and the concentration of serum 25-hydroxyvitamin D may affect the risk of endometriosis.[31] However, these observational studies may be confined by potential limitations (e.g., reverse causality and confounding factors), which obscure the true causal relationship.

In our study, the findings of our forward-direction MR analysis were inconsistent with the outcomes of earlier observational investigations. We did not detect any causative influence of serum 25-hydroxyvitamin D on endometriosis.

Our MR analysis helps clarify the relationship suggested in previous observational studies and found no evidence supporting a causal effect of serum 25-hydroxyvitamin D on endometriosis. The differences between the results obtained from observational and MR investigations can be attributed to the intrinsic advantage of the latter over the former, as well as methodological flaws in observational research.

4.2. Causative influence of endometriosis on serum 25-hydroxyvitamin D

Clinical research performed by Somigliana et al demonstrated that endometriosis was linked to higher levels of serum 25-hydroxyvitamin D.[32] Another clinical investigation on endometriosis patients discovered higher levels of vitamin D-binding protein (VDBP) in their urine.[33] However, according to an in vitro research study, women with severe endometriosis had considerably lower blood levels of 25-hydroxyvitamin D than controls and those with moderate endometriosis.[34] Nonetheless, whether endometriosis is responsible for the higher levels of serum 25-hydroxyvitamin D remains largely unexplored.

Recently, a bidirectional MR study by Pan D and colleagues published in Reproductive Sciences investigated the causal relationship between serum 25-hydroxyvitamin D levels and endometriosis. Their analysis suggested a potential bidirectional association between vitamin D status and the risk of endometriosis.[35] While their findings provide important insights into the interplay between vitamin D metabolism and endometriosis, our study differs in several aspects. First, we used a different GWAS dataset for serum 25-hydroxyvitamin D that included a larger sample size, which may improve the statistical power and robustness of the MR analysis.

Second, although both studies employed bidirectional MR approaches, our analysis further evaluated the potential causal influence of endometriosis on circulating vitamin D levels using additional sensitivity analyses. Therefore, our results provide complementary evidence supporting the possible interaction between endometriosis and vitamin D metabolism.

Our reverse-direction MR research provides suggestive evidence for a causal effect of endometriosis on serum 25-hydroxyvitamin D. If there is a causal effect, it is likely small and may reflect the inflammatory state of the disease. In line with clinical trial that human cycling endometrium may be one of the extrarenal locations capable of vitamin D synthesis.[8] The potential effect of endometriosis on 25-hydroxyvitamin D may be related to inflammation, as endometriosis is an inflammatory condition where macrophages mediate responses.[36] For instance, activated macrophages may produce 25-hydroxyvitamin D that spills into circulation.[37] A previous MR study indicated high levels of macrophage colony-stimulating factor (MCSF) are associated with increased risks of endometriosis.[38] However, this mechanism is speculative and should be framed as a hypothesis.

Our MR analyses were based on the PhenoScannerV2 database; hence, they are superior to existing observational research in terms of significantly reduced confounding bias.

4.3. Heterogeneity and pleiotropy

In addition, several heterogeneity and pleiotropy analyses were conducted to investigate potential pleiotropy. These analyses showed no significant heterogeneity or pleiotropy in the forward MR estimates (e.g., Q = 113.77, I2 = 0.171, P = .081; MR-Egger intercept = −0.0051, P = .171). For the reverse MR, no heterogeneity was detected (Q = 6.120, I2 = 0.340, P = .630), and MR-Egger regression indicated no directional pleiotropy (intercept = −0.003, P = .246).

The reverse MR finding showed conflicting results between methods, with only the IVW method being significant while more robust methods (MR-Egger and weighted median) were not. This implies that the evidence for a causal effect is suggestive but not conclusive, potentially due to pleiotropy or other biases, and warrants cautious interpretation and replication in future studies.

4.4. Implications

Our bidirectional MR analysis demonstrated no causal influence of 25-hydroxyvitamin D on endometriosis, with suggestive evidence for the reverse. These findings suggest that serum 25-hydroxyvitamin D levels may be a consequence of endometriosis rather than a causal risk factor. The present results may be important for public health because they could be used as a basis for further research on endometriosis and serum 25-hydroxyvitamin D. In addition, they provide new information regarding the presumed differences in the etiologies of endometriosis and alterations in serum 25-hydroxyvitamin D.

4.5. Strength and limitations

To our knowledge, this study provides additional MR evidence regarding the relationship between serum 25-hydroxyvitamin D and endometriosis using updated GWAS datasets. In comparison to observational studies, the enormous sample size of GWAS summary datasets used in MR considerably reduced the degree of reverse causation and confounding bias.

However, our research is also characterized by several limitations. First, we did not provide a physiological explanation regarding the correlation between 25-hydroxyvitamin D and endometriosis. Second, our investigation focused on individuals of European ancestry; consequently, the results may not accurately reflect the relationship between 25-hydroxyvitamin D and endometriosis in individuals of different ancestries, such as Asians and Blacks. Thus, further research is warranted to generalize the present findings to non-European populations. Third, although endometriosis exclusively affects women, the serum 25-hydroxyvitamin D GWAS utilized in this investigation included both male and female participants.

Therefore, if new GWAS on serum 25-hydroxyvitamin D in females become available, it would be intriguing to conduct a similar study. Fourth, the relatively small sample size of the endometriosis GWAS (n = 8288) may lead to weak instrument bias, although F-statistics were strong (>10). Finally, the credibility of findings may also be somewhat compromised by any error in measurement. Thus, additional research on this topic should be conducted when larger and more comprehensive datasets become available to the general public.[39,40]

Therefore, the causal estimate for this direction should be considered preliminary and requires validation in future studies with stronger genetic instruments and consistent results across MR methods.

5. Conclusion

Our bidirectional MR analysis produced evidence indicating that 25-hydroxyvitamin D is not causally associated with the risk of developing endometriosis. However, there is suggestive evidence that endometriosis may lead to slightly elevated serum 25-hydroxyvitamin D levels, though this finding is not robust across methods and requires further investigation.

Acknowledgments

The authors thank all the participants and researchers of the original genome-wide association studies who contributed and shared the summary statistics. We specifically acknowledge the MRC-IEU UK Biobank GWAS pipeline for the 25-hydroxyvitamin D data (accession: ebi-a-GCST90000618) and the FinnGen consortium for the endometriosis data (release R9, finn-b-N14_ENDOMETRIOSIS).

Author contributions

Conceptualization: Hongkun Jiang, Faquan Lin.

Data curation: Ximei Huang, Zila Wang.

Formal analysis: Hongkun Jiang.

Software: Hongkun Jiang, Yinghua Tang, Faquan Lin.

Visualization: Hongkun Jiang, Yinghua Tang, Faquan Lin.

Writing: original draft: Hongkun Jiang.

Writing: review & editing: Hongkun Jiang, Faquan Lin.

Supplement file at the original source: open the original paper. This file is not included in this text import.
Supplement file at the original source: open the original paper. This file is not included in this text import.

Abbreviations:

CI

confidence interval

EAF

effect allele frequency

GWAS

genome-wide association study

IV

instrumental variant

IVW

inverse variance-weighted

MR

Mendelian randomization

OR

odds ratio

SE

standard error

SNP

single-nucleotide polymorphism

Informed consent was obtained from all participants in the original genome-wide association studies that provided the summary data for this analysis.

The authors have no conflicts of interest to disclose.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Supplemental Digital Content is available in the online version of this article (http://dx.doi.org/10.1097/MD.0000000000048562).

This study analyzed publicly available, de-identified summary-level data from genome-wide association studies. Therefore, separate ethical approval was not required for this specific analysis. The original GWAS studies obtained ethical approval from their respective institutional review boards and informed consent from all participants.

How to cite this article: Jiang H, Tang Y, Huang X, Wang Z, Lin F. Causal effects of endometriosis on serum 25-hydroxyvitamin D: Evidence from Mendelian randomization study. Medicine 2026;105:19(e48562).

References

[1] Bulun SE Yilmaz BD Sison C . Endometriosis. Endocr Rev . 2019 ;40 :1048Not reported79 . 30994890 10.1210/er.2018-00242 PMC6693056
[2] Zondervan KT Becker CM Missmer SA . Endometriosis. N Engl J Med . 2020 ;382 :1244Not reported56 . 32212520 10.1056/NEJMra1810764
[3] Taylor HS Kotlyar AM Flores VA . Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet . 2021 ;397 :839Not reported52 . 33640070 10.1016/S0140-6736(21)00389-5
[4] França PRC Lontra ACP Fernandes PD . Endometriosis: a disease with few direct treatment options. Molecules . 2022 ;27 :4034 . 35807280 10.3390/molecules27134034 PMC9268675
[5] Bonavina G Taylor HS . Endometriosis-associated infertility: from pathophysiology to tailored treatment. Front Endocrinol (Lausanne) . 2022 ;13 :1020827 . 36387918 10.3389/fendo.2022.1020827 PMC9643365
[6] Liberman U Bikle DD . Disorders in the action of vitamin D. In: Feingold KR , eds. Endotext . MDText.com, Inc.; 2000 .
[7] Ao T Kikuta J Ishii M . The Effects of Vitamin D on Immune System and Inflammatory Diseases. Biomolecules . 2021 ;11 :1624 . 34827621 10.3390/biom11111624 PMC8615708
[8] Viganò P Lattuada D Mangioni S . Cycling and early pregnant endometrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol . 2006 ;36 :415Not reported24 . 16720713 10.1677/jme.1.01946
[9] Calcaterra V Magenes VC Tagi VM . Association between vitamin D levels, puberty timing, and age at menarche. Children (Basel) . 2023 ;10 :1243 . 37508740 10.3390/children10071243 PMC10378582
[10] Harris HR Chavarro JE Malspeis S Willett WC Missmer SA . Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol . 2013 ;177 :420Not reported30 . 23380045 10.1093/aje/kws247 PMC3626048
[11] Trabert B Peters U De Roos AJ Scholes D Holt VL . Diet and risk of endometriosis in a population-based case-control study. Br J Nutr . 2011 ;105 :459Not reported67 . 20875189 10.1017/S0007114510003661 PMC3374872
[12] Nodler JL Harris HR Chavarro JE Frazier AL Missmer SA . Dairy consumption during adolescence and endometriosis risk. Am J Obstet Gynecol . 2020 ;222 :257.e1Not reported257.e16 . 10.1016/j.ajog.2019.09.010 PMC7056553 31526789
[13] Parazzini F Chiaffarino F Surace M . Selected food intake and risk of endometriosis. Hum Reprod . 2004 ;19 :1755Not reported9 . 15254009 10.1093/humrep/deh395
[14] Smith GD Ebrahim S . “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol . 2003 ;32 :1Not reported22 . 12689998 10.1093/ije/dyg070
[15] Davey Smith G Hemani G . Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet . 2014 ;23 :R89Not reported98 . 25064373 10.1093/hmg/ddu328 PMC4170722
[16] Latvala A Ollikainen M . Mendelian randomization in (epi)genetic epidemiology: an effective tool to be handled with care. Genome Biol . 2016 ;17 :156 . 27418254 10.1186/s13059-016-1018-9 PMC4944517
[17] Davies NM Holmes MV Davey Smith G . Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ . 2018 ;362 :k601 . 30002074 10.1136/bmj.k601 PMC6041728
[18] Sekula P Del Greco M F Pattaro C Köttgen A . Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol . 2016 ;27 :3253Not reported65 . 27486138 10.1681/ASN.2016010098 PMC5084898
[19] Emdin CA Khera AV Kathiresan S . Mendelian Randomization. JAMA . 2017 ;318 :1925Not reported6 . 29164242 10.1001/jama.2017.17219
[20] Burgess S Thompson SG . Mendelian Randomization: Methods for Using Genetic Variants in Causal Estimation . Chapman and Hall/CRC; 2015 .
[21] Jiang X O’Reilly PF Aschard H . Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. Nat Commun . 2018 ;9 :260 . 29343764 10.1038/s41467-017-02662-2 PMC5772647
[22] Elsworth B Lyon M Alexander T . The MRC IEU OpenGWAS data infrastructure. bioRxiv [Preprint] . 2020 :2020.08.10.244293 .
[23] Burgess S Thompson SG ; CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol . 2011 ;40 :755Not reported64 . 21414999 10.1093/ije/dyr036
[24] Pierce BL Ahsan H Vanderweele TJ . Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol . 2011 ;40 :740Not reported52 . 20813862 10.1093/ije/dyq151 PMC3147064
[25] Garitazelaia A Rueda-Martínez A Arauzo R . A systematic two-sample Mendelian randomization analysis identifies shared genetic origin of endometriosis and associated phenotypes. Life (Basel) . 2021 ;11 :24 . 33401535 10.3390/life11010024 PMC7824623
[26] Staley JR Blackshaw J Kamat MA . PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics . 2016 ;32 :3207Not reported9 . 27318201 10.1093/bioinformatics/btw373 PMC5048068
[27] Kamat MA Blackshaw JA Young R . PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics . 2019 ;35 :4851Not reported3 . 31233103 10.1093/bioinformatics/btz469 PMC6853652
[28] Burgess S Thompson SG . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol . 2017 ;32 :377Not reported89 . 28527048 10.1007/s10654-017-0255-x PMC5506233
[29] Verbanck M Chen C-Y Neale B Do R . Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet . 2018 ;50 :693Not reported8 . 29686387 10.1038/s41588-018-0099-7 PMC6083837
[30] Bowden J Hemani G Davey Smith G . Invited commentary: detecting individual and global horizontal pleiotropy in Mendelian randomization-a job for the humble heterogeneity statistic? Am J Epidemiol . 2018 ;187 :2681Not reported5 . 30188969 10.1093/aje/kwy185 PMC6269239
[31] Sayegh L Fuleihan Gel H Nassar AH . Vitamin D in endometriosis: a causative or confounding factor? Metabolism . 2014 ;63 :32Not reported41 . 24135500 10.1016/j.metabol.2013.09.012
[32] Somigliana E Panina-Bordignon P Murone S Di Lucia P Vercellini P Vigano P . Vitamin D reserve is higher in women with endometriosis. Hum Reprod . 2007 ;22 :2273Not reported8 . 17548365 10.1093/humrep/dem142
[33] Faserl K Golderer G Kremser L . Polymorphism in vitamin D-binding protein as a genetic risk factor in the pathogenesis of endometriosis. J Clin Endocrinol Metab . 2011 ;96 :E233Not reported41 . 20980430 10.1210/jc.2010-1532
[34] Miyashita M Koga K Izumi G . Effects of 1,25-Dihydroxy vitamin D3 on endometriosis. J Clin Endocrinol Metab . 2016 ;101 :2371Not reported9 . 27035829 10.1210/jc.2016-1515
[35] Pan D Li P Dai X Xie S . 25-hydroxyvitamin D and endometriosis: a bidirectional Mendelian randomization study. Reprod Sci . 2025 ;32 :693Not reported701 . 38512698 10.1007/s43032-024-01517-8
[36] Lim YH Yoon G Ryu Y . Human lncRNA SUGCT-AS1 regulates the proinflammatory response of macrophage. Int J Mol Sci . 2023 ;24 :13315 . 37686120 10.3390/ijms241713315 PMC10487982
[37] Sharma OP . Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med . 2000 ;6 :442Not reported7 . 10958237 10.1097/00063198-200009000-00010
[38] Lin Y Wang G Li Y . Circulating inflammatory cytokines and female reproductive diseases: a Mendelian randomization analysis. J Clin Endocrinol Metab . 2023 ;108 :3154Not reported64 . 37350485 10.1210/clinem/dgad376
[39] Revez JA Lin T Qiao Z . Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun . 2020 ;11 :1647 . 32242144 10.1038/s41467-020-15421-7 PMC7118120
[40] Kurki MI Karjalainen J Palta P ; FinnGen. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature . 2023 ;613 :508Not reported18 . 36653562 10.1038/s41586-022-05473-8 PMC9849126
Publication and source details

Original title: Causal effects of endometriosis on serum 25-hydroxyvitamin D: Evidence from Mendelian randomization study

Hongkun Jiang; Yinghua Tang; Ximei Huang; Zila Wang; Faquan Lin

Medicine · 2026

* Correspondence: Faquan Lin, Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, No. 6 Shuangyong Road, Nanning 530021, Guangxi, China (e-mail: faquanlin@163.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:40:07.050161+00:00

DOI: 10.1097/md.0000000000048562 · PMC13166774